PMID: 6986969Feb 15, 1980Paper

Tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal patients with advanced breast cancer: a randomized trial

Cancer
J H GlickM Varano

Abstract

Eighty-nine postmenopausal women with metastatic breast cancer, in whom estrogen receptors (ER) were positive or unknown, were treated on a controlled trial to determine the effectiveness of tamoxifen and to assess the therapeutic advantage of sequentially adding low-dose cyclophosphamide-methotrexate-5-fluorouracil (CMF) chemotherapy in tamoxifen responders. Patients with known ER negative status were not studied. After the initial 12 week treatment with tamoxifen alone, 59% of ER positive patients achieved complete or partial response as did 35% in whom ER were unknown. Response status further improved in 18% randomized to continue tamoxifen alone vs. 28% in whom CMF was added to tamoxifen. There were no statistically significant differences in time to the development of progressive disease or survival between the ER positive and ER unknown patients or between the tamoxifen and tamoxifen plus CMF groups. We conclude that inability to determine ER status should not prejudice against the use of tamoxifen in postmenopausal patients with advanced breast cancer. As yet, no benefit has been demonstrated from the addition of CMF chemotherapy in tamoxifen responders.

References

Jan 14, 1978·Lancet·J S Patterson, M Baum
Jan 1, 1978·Annals of Internal Medicine·S S LeghaF M Muggia
Dec 1, 1977·Annals of Internal Medicine·D T Kiang, B J Kennedy
Jan 1, 1973·The Journal of Clinical Investigation·W L McGuire
Mar 1, 1974·Ultrasound in Medicine & Biology·R C Heyser, D H Le Croissette

❮ Previous
Next ❯

Citations

Jun 26, 2002·The Journal of Pathology·S SchweyerA Fayyazi
Jan 1, 1983·Breast Cancer Research and Treatment·J H Goldie
Dec 1, 1985·Journal of Steroid Biochemistry·M R SertoliR Rosso
Jan 1, 1988·Pharmacology & Therapeutics·L E Damon, E C Cadman
Jun 1, 1988·Archives of Gerontology and Geriatrics·L BalducciC L Hardy
Dec 1, 1993·The Journal of Steroid Biochemistry and Molecular Biology·C K Osborne
Apr 3, 2013·European Journal of Pharmacology·Berta SousaFatima Cardoso
Oct 5, 2002·Cancer Treatment Reviews·M ClemonsA Howell
Jan 1, 1991·Critical Reviews in Oncology/hematology·J T Hamm, J C Allegra
Apr 1, 1996·The Surgical Clinics of North America·T M LawM J Lopez
Nov 1, 1994·Cancer·L G FordB S Kramer
Jun 15, 2021·Breast Cancer Research and Treatment·Yoanna S PumpalovaAlfred I Neugut
Oct 13, 1998·Cancer Treatment Reviews·G Y Locker
Jan 1, 1984·Medical Oncology and Tumor Pharmacotherapy·L S Perlow, J F Holland

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.